A superagonist variant of peptide MART1/melan A27-35 elicits anti- melanoma CD8+ T cells with enhanced functional characteristics: Implication for more effective immunotherapy

Licia Rivoltini, Paola Squarcina, Douglas J. Loftus, Chiara Castelli, Paolo Tarsini, Arabella Mazzocchi, Francesca Rini, Vincenzo Viggiano, Filiberto Belli, Giorgio Parmiani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A superagonist variant of peptide MART1/melan A27-35 elicits anti- melanoma CD8+ T cells with enhanced functional characteristics: Implication for more effective immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences